Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1300026	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Import Drug Application	2013-04-18	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S	Certificate Issued	2015-08-06	view
JXSL1300025	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Import Drug Application	2013-04-26	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S	Certificate Issued	2015-08-06	view
CXSL2100112	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products(3.3)	New Drug Application	2021-04-02	吉林惠升生物制药有限公司	Jilin Huisheng Biopharmaceutical Co Ltd	In Review	2021-04-01	view
JYSF1900005	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-06-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JYSB2000681	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-12-30	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-12-30	view
JYSB1900351	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-12-19	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-17	view
JYSB2000138	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-04-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-04-23	view
JYSB1900126	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-06-19	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JXSS1800012	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Import Drug Application	2018-05-07	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-05-28	view
JYSB1900125	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-06-19	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JXSS1800011	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Import Drug Application	2018-05-07	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-05-28	view
JYSB2000137	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-04-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-04-23	view
JYSF1900004	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-06-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2019-07-05	view
JYSB2000682	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2020-12-30	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-12-30	view
JYSB1900350	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2019-12-19	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-17	view
CXSS2300029	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products(3.3)	New Drug Application	2023-05-07		Jilin Huisheng Biopharmaceutical Co Ltd			view
CYSB2101148	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2021-08-12		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2300050	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	License Renew	2023-12-05		Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S			view
CXSL2200557	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products(3.3)	New Drug Application	2022-11-04		Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd			view
CYSB2101149	德谷门冬双胰岛素注射液	insulin degludec;Insulin Aspart	Injection	Biological Products	Supplementary Application	2021-08-12		Novo Nordisk (China) Pharmaceuticals Co Ltd			view